PDGFB, involved in vascular smooth muscle cell proliferation and ECM remodeling, may identify patients predisposed to aggressive medial hypertrophy, aligning with evidence that excessive PDGF signaling drives pathological vascular remodeling in PAH 45. The gene discussed is PDGFB; the disease is pulmonary arterial hypertension.